Influence of Incubation Time, Inoculum Size, and Glucose Concentrations on Spectrophotometric Endpoint Determinations for Amphotericin B, Fluconazole, and Itraconazole
- 1 January 1999
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 37 (1), 141-145
- https://doi.org/10.1128/jcm.37.1.141-145.1999
Abstract
We addressed the influence of the incubation time (24 h versus 48 h), starting inoculum size (standard inoculum size, ∼103 CFU/ml, versus large inoculum size, ∼104 CFU/ml), and supplementation with 2% glucose of RPMI 1640 medium on the spectrophotometric determination of the MICs of amphotericin B, fluconazole, and itraconazole. We compared the MICs determined spectrophotometrically with those determined by the standard broth macrodilution method (National Committee for Clinical Laboratory Standards approved guideline M27-A). The agreement between the results of the spectrophotometric and standard methods for amphotericin B testing was 100%; this agreement was independent of the inoculum size and incubation time. On the other hand, the agreement for the results for fluconazole testing and itraconazole testing was dependent on the inoculum size and incubation time. With large inoculum size, excellent agreement can be achieved at 24 h. With standard inoculum size, acceptable agreement can be achieved only at 48 h. In contrast to previous observations, the addition of 2% glucose did not have any significant impact on the growth density at 24 h, nor did it improve the agreement with the standard method. Furthermore, supplemental glucose might falsely elevate the MIC at 48 h.Keywords
This publication has 23 references indexed in Scilit:
- Do In Vitro Susceptibility Data Predict the Microbiologic Response to Amphotericin B? Results of a Prospective Study of Patients withCandidaFungemiaThe Journal of Infectious Diseases, 1998
- Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida InfectionsClinical Infectious Diseases, 1997
- The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistanceAmerican Journal Of Medicine, 1996
- Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automationAntimicrobial Agents and Chemotherapy, 1995
- Defining conditions for microbroth antifungal susceptibility tests: influence of RPMI and RPMI-2% glucose on the selection of endpoint criteriaJournal of Antimicrobial Chemotherapy, 1995
- Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standardJournal of Clinical Microbiology, 1994
- Improved medium for fluconazole susceptibility testing of Candida albicansAntimicrobial Agents and Chemotherapy, 1994
- Antifungal susceptibility testingClinical Microbiology Reviews, 1993
- Turbidimetric and visual criteria for determining the in vitro activity of six antifungal agents againstCandida spp. andCryptococcus neoformansMycopathologia, 1993
- In vitro studies of activities of some antifungal agents against Candida albicans ATCC 10231 by the turbidimetric methodAntimicrobial Agents and Chemotherapy, 1992